PHA Live is a monthly series of Facebook Live events and webinars that provides an opportunity for those affected by pulmonary hypertension (PH) to hear from experts on health, wellness, science and research topics. Recordings of PHA Live events will become available on this page within three business days of the original program.

Upcoming Events

PH and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Thursday, Oct. 28 at 3:30 p.m. EDT

Join the Pulmonary Hypertension Association (PHA) for the PHA Live event “PH and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)” on Thursday, Oct. 28 at 3:30 p.m. EDT. Ivan Robbins, M.D., will discuss CTEPH, highlight the importance of diagnosis and share treatment options for individuals with pulmonary hypertension (PH) related to chronic thromboembolic disease. Hear Dr. Robbins’s contributions to the evaluation and treatment of PH as director at the Adult Pulmonary Vascular Center and interim medical director of the Lung Transplant Program at Vanderbilt University. Interested participants may email us any questions they would like addressed by Monday, Oct. 25.

Register Now!

About the Speaker

Ivan Robbins

Ivan Robbins, M.D.
Ivan Robbins, M.D., is the director of the Adult Pulmonary Vascular Center and the interim medical director of the Lung Transplant Program at Vanderbilt University. He joined Vanderbilt in 1997 after completing a fellowship in pulmonary and critical care medicine at Vanderbilt University Medical Center. Dr. Robbins received his medical degree from Case Western Reserve School of Medicine and completed his residence at Metro Health Medical Center in Cleveland, Ohio. His educational tenure includes 23 years of studying pulmonary vascular disease and participating in over 20 published clinical trials that evaluated and treated individuals with CTEPH.

Additional resources
Free brochure: “Pulmonary Hypertension & Chronic Thromboembolic Disease”

Free Brochure: “What You Need to Know After a Pulmonary Embolism”

PHA thanks Janssen Pharmaceuticals for its Diamond Sponsorship and Bayer HealthCare for its Platinum Sponsorship of the PHA Connects Fund, which provides support to this PHA Live event.

PH and Left Heart Disease
Tuesday, Nov. 16 at 3:30 p.m. EST

Join the Pulmonary Hypertension Association (PHA) for the PHA Live event “PH and Left Heart Disease” on Tuesday, Nov. 16 at 3:30 p.m. EST. Vineet Agrawal, M.D., Ph.D., will discuss left heart disease and the various ways it can lead to pulmonary hypertension (PH), highlight the importance of accurate diagnosis and share treatment options. Hear Dr. Agrawal’s contributions to the evaluation and treatment of PH as assistant professor of medicine in the division of cardiovascular medicine at Vanderbilt University Medical Center.

Interested participants may email us at phawebinars@phassociation.org with any questions for Dr. Agrawal by Friday, Nov. 12.

Register Now!

About the Speaker

Vineet Agrawal, M.D., Ph.D.
Vineet Agrawal, M.D., Ph.D., is assistant professor of medicine in the division of cardiovascular medicine at Vanderbilt University Medical Center. He completed his bachelor’s degree in electrical and biomedical engineering at Duke University. Dr. Agrawal earned his medical degree and Ph.D. in cellular and molecular pathology at the University of Pittsburgh. He completed his internal medicine training at Johns Hopkins Hospital and his clinical fellowship at Vanderbilt University Medical Center.

Dr. Agrawal’s research is focused on understanding the biologic mechanisms that lead to the development of heart failure with preserved ejection fraction (HFpEF), pulmonary hypertension due to left heart disease, and specifically right ventricular dysfunction.

PHA thanks Janssen Pharmaceuticals for its Diamond Sponsorship of the Associated Disease Outreach & Engagement Program, which provides support to this PHA Live event.

Watch Previous PHA Live Events

2021-09-17T07:56:48-04:00

PH and Congenital Heart Disease

John T. Berger III, M.D., discusses congenital heart disease (CHD) and reviews types of heart and blood vessel abnormalities that can develop before a person is born that could lead to pulmonary hypertension (PH). PHA thanks Janssen Pharmaceuticals for its Diamond Sponsorship of the Associated Disease Outreach & Engagement Program, which provides support to this PHA Live event.

2021-08-19T15:29:20-04:00

A Conversation About the PHA Registry

Dan Grinnan, M.D., speaks with one of his pulmonary hypertension (PH) patients, Shirl Rhodes, about her enrollment in the PHA Registry (PHAR), a registry of patients with pulmonary arterial hypertension (PAH), pediatric PH due to developmental lung disease and chronic thromboembolic pulmonary hypertension (CTEPH). Learn what it is like to participate in the PHAR and how PHAR supports PH research. PHA thanks Bayer for its Platinum Sponsorship and Janssen Pharmaceuticals, Inc. for its Diamond Sponsorship of the PHA Connects fund, which provides support to this PHA Live event.

2021-07-30T11:35:06-04:00

PHA Research Room Findings

Scientists and clinicians present findings from the 2018 PHA Research Room, the Pulmonary Hypertension Association (PHA)’s research project providing pulmonary hypertension (PH) patients the opportunity to participate in clinical research studies. Learn about pulmonary arterial hypertension (PAH) biomarkers, patient survey results from support group therapy, an outcomes risk assessment tool for PH patients and barriers to exercise therapy in PH. PHA thanks Bayer for its Platinum Sponsorship and Janssen Pharmaceuticals, Inc. for its Diamond Sponsorship of the PHA Connects fund, which provides support to this PHA Live event.

2021-04-01T15:19:17-04:00

PH and Your Child

Dr. Eric Austin discusses how pulmonary hypertension (PH) affects children and answers common questions about heritable pulmonary atrial hypertension (PAH). The event will help parents to understand how pediatric PH is treated. PHA thanks Janssen Pharmaceuticals, Inc. for its diamond sponsorship of the PHA Connects fund, which provides support to this PHA Live event.

PHA thanks Janssen Pharmaceuticals, Inc. for its diamond sponsorship and Bayer for its platinum sponsorship of the PHA Connects fund, which provides support to this PHA Live event.